BioCatalyst

TARS — Tarsus Pharmaceuticals, Inc. catalysts

1 verified catalyst event(s) for Tarsus Pharmaceuticals, Inc. (ticker TARS). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-12-31 — Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 3mo
ESTIMATED
 READOUT
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
Phase 2 · Ocular Rosacea
 TARS Tarsus Pharmaceuticals, Inc. lotilaner, Vehicle ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.